Your browser doesn't support javascript.
loading
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.
Wefers, Annika K; Stichel, Damian; Schrimpf, Daniel; Coras, Roland; Pages, Mélanie; Tauziède-Espariat, Arnault; Varlet, Pascale; Schwarz, Daniel; Söylemezoglu, Figen; Pohl, Ute; Pimentel, José; Meyer, Jochen; Hewer, Ekkehard; Japp, Anna; Joshi, Abhijit; Reuss, David E; Reinhardt, Annekathrin; Sievers, Philipp; Casalini, M Belén; Ebrahimi, Azadeh; Huang, Kristin; Koelsche, Christian; Low, Hu Liang; Rebelo, Olinda; Marnoto, Dina; Becker, Albert J; Staszewski, Ori; Mittelbronn, Michel; Hasselblatt, Martin; Schittenhelm, Jens; Cheesman, Edmund; de Oliveira, Ricardo Santos; Queiroz, Rosane Gomes P; Valera, Elvis Terci; Hans, Volkmar H; Korshunov, Andrey; Olar, Adriana; Ligon, Keith L; Pfister, Stefan M; Jaunmuktane, Zane; Brandner, Sebastian; Tatevossian, Ruth G; Ellison, David W; Jacques, Thomas S; Honavar, Mrinalini; Aronica, Eleonora; Thom, Maria; Sahm, Felix; von Deimling, Andreas; Jones, David T W.
  • Wefers AK; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany. annika.wefers@med.uni-heidelberg.de.
  • Stichel D; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. annika.wefers@med.uni-heidelberg.de.
  • Schrimpf D; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany. annika.wefers@med.uni-heidelberg.de.
  • Coras R; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Pages M; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Tauziède-Espariat A; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Varlet P; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schwarz D; Department of Neuropathology, University Hospital Erlangen, Erlangen, Germany.
  • Söylemezoglu F; Department of Neuropathology, Sainte-Anne Hospital, Descartes University, Paris, France.
  • Pohl U; Department of Neuropathology, Sainte-Anne Hospital, Descartes University, Paris, France.
  • Pimentel J; Department of Neuropathology, Sainte-Anne Hospital, Descartes University, Paris, France.
  • Meyer J; Department of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany.
  • Hewer E; Department of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Japp A; Department of Pathology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Joshi A; Department of Cellular Pathology, Queen's Hospital BHRUT, Romford, UK.
  • Reuss DE; Department of Cellular Pathology, Queen Elizabeth Hospital Birmingham/University Hospitals Birmingham, Birmingham, UK.
  • Reinhardt A; Department of Neurosciences and Mental Health, Laboratory of Neuropathology, Hospital de Santa Maria (CHULN, EPE), Lisbon, Portugal.
  • Sievers P; Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
  • Casalini MB; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Ebrahimi A; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Huang K; Institute of Pathology, University of Bern, Bern, Switzerland.
  • Koelsche C; Department of Neuropathology, University of Bonn, Bonn, Germany.
  • Low HL; Department of Neuropathology, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
  • Rebelo O; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Marnoto D; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Becker AJ; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Staszewski O; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Mittelbronn M; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Hasselblatt M; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schittenhelm J; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Cheesman E; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • de Oliveira RS; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Queiroz RGP; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Valera ET; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Hans VH; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Korshunov A; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Olar A; Department of General Pathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Ligon KL; Department of Neurosurgery, Queen's Hospital BHRUT, Romford, UK.
  • Pfister SM; Neuropathology Unit, Centro Hospitalar de Universidades de Coimbra, Coimbra, Portugal.
  • Jaunmuktane Z; Neuropathology Unit, Centro Hospitalar de Universidades de Coimbra, Coimbra, Portugal.
  • Brandner S; Department of Neuropathology, University of Bonn, Bonn, Germany.
  • Tatevossian RG; Institute of Neuropathology, University of Freiburg, Freiburg, Germany.
  • Ellison DW; Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt, Germany.
  • Jacques TS; Luxembourg Center of Neuropathology (LCNP), Dudelange, Luxembourg.
  • Honavar M; Laboratoire National de Santé (LNS), National Center of Pathology (NCP), Dudelange, Luxembourg.
  • Aronica E; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Thom M; Department of Oncology (DONC), Luxembourg Institute of Health (LIH), Luxembourg City, Luxembourg.
  • Sahm F; Institute of Neuropathology, University Hospital Münster, Münster, Germany.
  • von Deimling A; Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital of Tübingen, Tübingen, Germany.
  • Jones DTW; Center for CNS Tumours, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital of Tübingen, Tübingen, Germany.
Acta Neuropathol ; 139(1): 193-209, 2020 01.
Article en En | MEDLINE | ID: mdl-31563982
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Transactivadores / Proteínas Proto-Oncogénicas / Proteínas Proto-Oncogénicas c-myb / Glioma Tipo de estudio: Prognostic_studies Límite: Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Transactivadores / Proteínas Proto-Oncogénicas / Proteínas Proto-Oncogénicas c-myb / Glioma Tipo de estudio: Prognostic_studies Límite: Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article